卵巢癌女性保留生育功能手术后的结局:一项系统综述
该系统综述检索PubMed 1995年1月1日至2020年5月29日文献,最终纳入上皮性卵巢癌44项研究、交界性卵巢肿瘤42项研究、非上皮性卵巢癌31项研究。叙事性合成显示,与常规手术相比,接受保留生育功能手术者的总生存似乎未受影响,但长期数据有限;术后妊娠和活产率令人鼓舞。
要点
- 早期低危卵巢癌女性行保留生育功能手术安全可行。
- 保留生育功能手术者总生存似乎未较常规手术者受损,但长期数据有限。
- 术后妊娠结局似乎与一般人群相似,但可能存在一定生育力受损。
核心结论
- 保留生育功能手术对早期低危卵巢癌女性安全可行,这些患者的妊娠结局似乎与一般人群相似。
研究设计与样本
- 系统综述,检索PubMed 1995年1月1日至2020年5月29日文献,纳入18至50岁卵巢癌女性的研究、报告保留生育功能手术后肿瘤学和/或生殖结局、且至少纳入20例患者。
- 初检获995项研究,去重后摘要980条独特引文,筛选后167篇可能相关并评估纳入排除标准,最终纳入上皮性卵巢癌44项研究、交界性卵巢肿瘤42项研究、非上皮性卵巢癌31项研究。
主要发现
- 叙事性合成显示,与常规手术相比,接受保留生育功能手术者的总生存似乎未受影响,但长期数据有限。
- 争议领域包括高危因素(IC期、3级和透明细胞组织学)下保留生育功能手术的安全性,以及手术类型(输卵管卵巢切除术vs囊肿切除术)。
- 术后似乎可能存在一定生育力受损,但妊娠率和活产率令人鼓舞。
局限性
- 长期数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare reproductive and oncologic outcomes of patients diagnosed with early-stage epithelial ovarian carcinoma, borderline ovarian tumors, or nonepithelial ovarian carcinoma according to receipt of fertility-sparing surgery or conventional surgery. DATA SOURCES: PubMed was searched from January 1, 1995, to May 29, 2020. METHODS OF STUDY SELECTION: Studies were included if they (1) enrolled women of childbearing age diagnosed with ovarian cancer between the ages of 18 years and 50 years, (2) reported on oncologic and/or reproductive outcomes after fertility-sparing surgery for ovarian cancer, and (3) included at least 20 patients. TABULATION, INTEGRATION, AND RESULTS: The initial search identified 995 studies. After duplicates were removed, we abstracted 980 unique citations. Of those screened, 167 publications were identified as potentially relevant, and evaluated for inclusion and exclusion criteria. The final review included 44 studies in epithelial ovarian cancer, 42 in borderline ovarian tumors, and 31 in nonepithelial ovarian carcinoma. The narrative synthesis demonstrated that overall survival does not seem to be compromised in patients undergoing fertility-sparing surgery compared with those undergoing conventional surgery, although long-term data are limited. Areas of controversy include safety of fertility-sparing surgery in the setting of high-risk factors (stage IC, grade 3, and clear cell histology), as well as type of surgery (salpingo-oophorectomy vs cystectomy). It seems that although there may be some fertility compromise after surgery, pregnancy and live-birth rates are encouraging. CONCLUSION: Fertility-sparing surgery is safe and feasible in women with early-stage low-risk ovarian cancer. Pregnancy outcomes for these patients also seem to be similar to those of the general population.
引用
- Bercow A, Nitecki R, Brady PC, et al. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature. J Minim Invasive Gynecol. 2020. PMID: 32861046. doi:10.1016/j.jmig.2020.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。